News
AC Health, the healthcare arm of conglomerate Ayala Corp., said it is aiming to become a $2-billion healthcare enterprise by 2035. AC Health President and CEO Paolo Borromeo said the company’s value ...
World Immunization Week reminds us of a simple but profound truth: vaccines save lives. This April, however, the call is even louder — not just to remember, but to act. Under the theme “Immunization ...
As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...
Islamabad: Pakistani health authorities have initiated "emergency preparedness" measures to secure pharmaceutical supplies in response to the suspension of trade ties with India, according to a media ...
Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions ...
The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...
Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...
Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...
The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...
In the high-stakes world of pharmaceutical manufcturing, where regulatory compliance meets razor-thin margins and patient safety, one industry leader is redefining what Lean transformation means in ...
With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...
Amid growing anxiety over tariffs, one medical center has warned its suppliers that any sudden price hikes attributed to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results